ReP USP - Resultado da busca

Artigo de periodico
Use of N-acetylcysteine as treatment adjuvant regulates immune response in visceral leishmaniasis: Pilot clinical trial and in vitro experiments (2022)
Magalhães, Lucas Sousa; Melo, Enaldo Vieira; Damascena, Nayra Prata; Albuquerque, Adriana Cardoso Batista; Santos, Camilla Natália Oliveira; Rebouças, Mônica Cardozo; Bezerra, Mariana de Oliveira; Silva, Ricardo Louzada da; Oliveira, Fabricia Alvisi de; Santos, Priscila Lima; Silva, João Santana da ; Lipscomb, Michael Wheeler; Silva, Ângela Maria da; Jesus, Amélia Ribeiro de; Almeida, Roque Pacheco de
Fonte: Frontiers in Cellular and Infection Microbiology. Unidade: FMRP
Assuntos: LEISHMANIOSE VISCERAL, QUIMIOTERAPIA ADJUVANTE, FARMACOTERAPIA, INTERLEUCINA 10, LEUCÓCITOS MONONUCLEARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAGALHÃES, Lucas Sousa et al. Use of N-acetylcysteine as treatment adjuvant regulates immune response in visceral leishmaniasis: Pilot clinical trial and in vitro experiments. Frontiers in Cellular and Infection Microbiology, v. 12, 2022Tradução . . Disponível em: https://doi.org/10.3389/fcimb.2022.1045668. Acesso em: 03 jul. 2024.
APA
Magalhães, L. S., Melo, E. V., Damascena, N. P., Albuquerque, A. C. B., Santos, C. N. O., Rebouças, M. C., et al. (2022). Use of N-acetylcysteine as treatment adjuvant regulates immune response in visceral leishmaniasis: Pilot clinical trial and in vitro experiments. Frontiers in Cellular and Infection Microbiology, 12. doi:10.3389/fcimb.2022.1045668
NLM
Magalhães LS, Melo EV, Damascena NP, Albuquerque ACB, Santos CNO, Rebouças MC, Bezerra M de O, Silva RL da, Oliveira FA de, Santos PL, Silva JS da, Lipscomb MW, Silva ÂM da, Jesus AR de, Almeida RP de. Use of N-acetylcysteine as treatment adjuvant regulates immune response in visceral leishmaniasis: Pilot clinical trial and in vitro experiments [Internet]. Frontiers in Cellular and Infection Microbiology. 2022 ; 12[citado 2024 jul. 03 ] Available from: https://doi.org/10.3389/fcimb.2022.1045668
Vancouver
Magalhães LS, Melo EV, Damascena NP, Albuquerque ACB, Santos CNO, Rebouças MC, Bezerra M de O, Silva RL da, Oliveira FA de, Santos PL, Silva JS da, Lipscomb MW, Silva ÂM da, Jesus AR de, Almeida RP de. Use of N-acetylcysteine as treatment adjuvant regulates immune response in visceral leishmaniasis: Pilot clinical trial and in vitro experiments [Internet]. Frontiers in Cellular and Infection Microbiology. 2022 ; 12[citado 2024 jul. 03 ] Available from: https://doi.org/10.3389/fcimb.2022.1045668
Artigo de periodico
BALB/c mice infected with antimony treatment refractory isolate of Leishmania braziliensis present severe lesions due to IL-4 production (2011)
Costa, Diego Luís; Carregaro, Vanessa; Lima Júnior, Djalma de Souza; Silva, Neide Maria da; Milanezi, Cristiane Maria; Cardoso, Cristina Ribeiro de Barros; Giudice, Ângela; Jesus, Amélia Ribeiro de; Carvalho, Edgar Marcelino; Almeida, Roque Pacheco de; Silva, João Santana da
Fonte: PLoS Neglected Tropical Diseases. Unidades: FMRP, FCFRP
Assuntos: LEISHMANIOSE CUTÂNEA, INFECÇÕES POR PROTOZOÁRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Diego Luís et al. BALB/c mice infected with antimony treatment refractory isolate of Leishmania braziliensis present severe lesions due to IL-4 production. PLoS Neglected Tropical Diseases, v. 5, n. 3, 2011Tradução . . Disponível em: https://repositorio.usp.br/directbitstream/c778e156-f28c-4593-8b74-fd327a267f15/002249147.pdf. Acesso em: 03 jul. 2024.
APA
Costa, D. L., Carregaro, V., Lima Júnior, D. de S., Silva, N. M. da, Milanezi, C. M., Cardoso, C. R. de B., et al. (2011). BALB/c mice infected with antimony treatment refractory isolate of Leishmania braziliensis present severe lesions due to IL-4 production. PLoS Neglected Tropical Diseases, 5( 3). Recuperado de https://repositorio.usp.br/directbitstream/c778e156-f28c-4593-8b74-fd327a267f15/002249147.pdf
NLM
Costa DL, Carregaro V, Lima Júnior D de S, Silva NM da, Milanezi CM, Cardoso CR de B, Giudice Â, Jesus AR de, Carvalho EM, Almeida RP de, Silva JS da. BALB/c mice infected with antimony treatment refractory isolate of Leishmania braziliensis present severe lesions due to IL-4 production [Internet]. PLoS Neglected Tropical Diseases. 2011 ; 5( 3):[citado 2024 jul. 03 ] Available from: https://repositorio.usp.br/directbitstream/c778e156-f28c-4593-8b74-fd327a267f15/002249147.pdf
Vancouver
Costa DL, Carregaro V, Lima Júnior D de S, Silva NM da, Milanezi CM, Cardoso CR de B, Giudice Â, Jesus AR de, Carvalho EM, Almeida RP de, Silva JS da. BALB/c mice infected with antimony treatment refractory isolate of Leishmania braziliensis present severe lesions due to IL-4 production [Internet]. PLoS Neglected Tropical Diseases. 2011 ; 5( 3):[citado 2024 jul. 03 ] Available from: https://repositorio.usp.br/directbitstream/c778e156-f28c-4593-8b74-fd327a267f15/002249147.pdf
Artigo de periodico
The −2518 bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil (2010)
Ramasawmy, Rajendranath; Menezes, Eliane; Magalhães, Andrea; Oliveira, Joyce; Castellucci, Léa; Almeida, Roque; Rosa, Maria Elisa A.; Guimães, Luiz Henrique; Lessa, Marcus; Noronha, Elza; Wilson, Mary E.; Jamieson, Sarra E.; Kalil, Jorge; Blackwell, Jenefer M.; Carvalho, Edgar M.; Jesus, Amélia Ribeiro de
Fonte: Infection, Genetics and Evolution. Unidade: FM
Assuntos: POLIMORFISMO, INFLAMAÇÃO, GENÓTIPOS, LEISHMANIOSE CUTÂNEA (GENÉTICA), BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAMASAWMY, Rajendranath et al. The −2518 bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil. Infection, Genetics and Evolution, v. 10, n. 5, p. 607-613, 2010Tradução . . Disponível em: http://www.sciencedirect.com/science/article/pii/S1567134810001048. Acesso em: 03 jul. 2024.
APA
Ramasawmy, R., Menezes, E., Magalhães, A., Oliveira, J., Castellucci, L., Almeida, R., et al. (2010). The −2518 bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil. Infection, Genetics and Evolution, 10( 5), 607-613. doi:10.1016/j.meegid.2010.04.006
NLM
Ramasawmy R, Menezes E, Magalhães A, Oliveira J, Castellucci L, Almeida R, Rosa MEA, Guimães LH, Lessa M, Noronha E, Wilson ME, Jamieson SE, Kalil J, Blackwell JM, Carvalho EM, Jesus AR de. The −2518 bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil [Internet]. Infection, Genetics and Evolution. 2010 ; 10( 5): 607-613.[citado 2024 jul. 03 ] Available from: http://www.sciencedirect.com/science/article/pii/S1567134810001048
Vancouver
Ramasawmy R, Menezes E, Magalhães A, Oliveira J, Castellucci L, Almeida R, Rosa MEA, Guimães LH, Lessa M, Noronha E, Wilson ME, Jamieson SE, Kalil J, Blackwell JM, Carvalho EM, Jesus AR de. The −2518 bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil [Internet]. Infection, Genetics and Evolution. 2010 ; 10( 5): 607-613.[citado 2024 jul. 03 ] Available from: http://www.sciencedirect.com/science/article/pii/S1567134810001048

Unidades USP

ReP

Filtros

Autores

Assuntos

Indexado em

Afiliação dos autores externos não normalizada